Target intelligence / Profile preview

Amyloid Beta Protein Aggregate (Aβ Aggregate)

Target
Aβ Aggregate
Molecular classification
Protein Aggregate, Misfolded Protein, Amyloid
01

Overview

Amyloid beta (Aβ) protein aggregates are misfolded assemblies of the amyloid beta peptide, a central molecule in the pathology of Alzheimer’s disease (AD). These aggregates form through a complex process involving monomeric Aβ peptides assembling into soluble oligomers, protofibrils, and eventually insoluble fibrils that deposit as plaques in brain tissue. The aggregation is highly polymorphic and can result in structures with diverse morphologies and toxicities. Soluble oligomeric forms are considered particularly neurotoxic, disrupting synaptic function before plaque deposition occurs. Aggregates mediate cell-to-cell transmission within the brain and induce neuroinflammation by activating microglia.

Other names
Amyloid beta oligomersAmyloid beta fibrilsAβ plaquesAmyloid beta aggregates
02

Mechanism of action

Antibody-mediated clearance of amyloid beta aggregates, inhibition of amyloid beta aggregation

03

Biological functions

NeurotoxicityMicroglial activationNeuroinflammationCell-to-cell transmission of misfolded proteinsSynaptic dysfunction
04

Disease associations

Alzheimer's DiseaseCerebral Amyloid Angiopathy
05

Safety considerations

Amyloid-Related Imaging Abnormalities (ARIA)MicrohemorrhagesEdemaInfusion-related reactions
06

Interacting drugs

Aducanumab

2 more in the full profile.

07

Biomarkers

Amyloid PET imagingCerebrospinal fluid Aβ42/Aβ40 ratioPlasma Aβ42/Aβ40 ratio

Beyond the preview

Go deeper on Amyloid Beta Protein Aggregate (Aβ Aggregate).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Amyloid Beta Protein Aggregate (Aβ Aggregate).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call